Researchers question the long-term use of antipsychotics and suggest increased research and investment in psychosocial interventions.
“Short and simple psychological programs can prevent people from relapsing when they stop their antidepressants.”
The FDA collaborated with Biogen to conduct repeated re-analyses of aducanumab for Alzheimer's and FDA committee members are raising concerns.
Hanna Pickard on the elusive middle ground between personal responsibility and systemic factors in our understandings of addiction.
Researchers again debunk the claim that the FDA black box warnings on antidepressants led to more suicides.
A new study published in JAMA Psychiatry connects antipsychotics with damage to the brain in multiple areas.
MIA’s Ayurdhi Dhar interviews Sunil Bhatia about decolonizing psychology, confronting the field’s racist past, colonial foundations, and neoliberal present.
Researchers have found further evidence that the anticholinergic effect of psychiatric drugs can lead to cognitive impairments.
People with "serious mental illness" who stop taking antipsychotics are more likely to recover, even when accounting for baseline severity.
Medical researchers present evidence that ADHD is overdiagnosed in children and teens, which can lead to significant harm.
Bias and financial conflicts in antidepressant trials “contribute to systematic underestimation of risk in the published literature.”
Researchers confirm that the suicide warning for antidepressants is justified by the evidence and that claims that the warning is harmful lack support.
In the first systematic review of withdrawal problems that patients experience when trying to get off SSRI antidepressant medications, researchers found that withdrawing from SSRIs was comparable to trying to quit addictive benzodiazepines.
Adverse physiological symptoms of antidepressant withdrawal are regularly mistaken to be other problems to the detriment of the patient.
Researchers find a lack of current literature on safe, effective ways to manage antidepressant withdrawal and make suggestions for future research.
MIA’s Ayurdhi Dhar interviews Ian Parker about critical psychology, discourse and political action, and whether psychology has anything left to offer.
A new study suggests that taking antidepressants impairs empathy, while the experience of depression itself does not.
A large study of the population in Taiwan reveals that long-term use of benzodiazepine drugs, commonly prescribed for anxiety, significantly increases the risk for brain, colorectal, and lung cancers. The research, published open-access in the journal Medicine, also identifies the types of benzodiazepines that carry the greatest cancer risk.
The prominent psychiatrist explores why antidepressants remain highly overprescribed and offers solutions to the problem.
Robin Williams had "therapeutic" levels of the tetra-cyclic antidepressant mirtazapine in his blood at the time of his suicide, according to the coroner's report...
An analysis of FDA adverse event reports related to esketamine shows the potential for negative effects such as suicidal and self-injurious ideation.
Protracted Withdrawal Syndrome characterized by long-term adverse experiences after coming off of antidepressants.
People who take anticholinergic drugs, such as antidepressants and antipsychotics, are at a 50% higher risk of dementia.
Royal College of Psychiatrists’ former president demands support for patients coming off antidepressants.
A new study, published in the JAMA Psychiatry, investigates the effect of stimulant ‘ADHD’ drugs on the brains of children and young adults. The...